Back to Journals » Therapeutics and Clinical Risk Management » Volume 7
![](https://www.dovepress.com/cr_data/cache/journal_image/1/cope/thumb_100_1000_100.jpg)
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2348)
- Volume 20, 2024 (40)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 7, 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
Bhandari S
Therapeutics and Clinical Risk Management 2011, 7:501-509
Published Date: 12 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial
Al Qahtani NH, Al Hajeri F
Therapeutics and Clinical Risk Management 2011, 7:495-500
Published Date: 8 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging patient safety issues under health care reform: follow-on biologics and immunogenicity
Liang BA, Mackey T
Therapeutics and Clinical Risk Management 2011, 7:489-493
Published Date: 7 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of ticagrelor in the management of acute coronary syndrome
Nawarskas JJ, Snowden SS
Therapeutics and Clinical Risk Management 2011, 7:473-488
Published Date: 5 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Zofenopril and incidence of cough: a review of published and unpublished data
Omboni S, Borghi C
Therapeutics and Clinical Risk Management 2011, 7:459-471
Published Date: 29 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions
Konda VJA, Dalal K
Therapeutics and Clinical Risk Management 2011, 7:447-458
Published Date: 22 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients
Minzi OM, Mugoyela V, Gustafsson LL
Therapeutics and Clinical Risk Management 2011, 7:441-446
Published Date: 22 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
Gori B, Ricciardi S, Fulvi A, Intagliata S, Del Signore E, de Marinis F
Therapeutics and Clinical Risk Management 2011, 7:429-440
Published Date: 17 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of iron supplementation in promoting maternal and fetal outcome
Yekta Z, Pourali R, Mladkova N, Ghasemi-rad M , Boromand F, Hazrati Tappeh K
Therapeutics and Clinical Risk Management 2011, 7:421-428
Published Date: 31 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009–2010 season: web-based and telephone evaluation
Wade AG, Crawford GM, Pumford N, McConnachie A
Therapeutics and Clinical Risk Management 2011, 7:409-420
Published Date: 21 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
Casanova M, Medina-Pérez A, Moreno-Beltran M, Mata-Vazquez M, Rueda A
Therapeutics and Clinical Risk Management 2011, 7:401-408
Published Date: 7 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients
Argoff CE, Gloth FM
Therapeutics and Clinical Risk Management 2011, 7:393-399
Published Date: 20 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cancer patient-centered home care: a new model for health care in oncology
Tralongo P, Ferraù F, Borsellino N, Verderame F, Caruso M, Giuffrida D, Butera A, Gebbia V
Therapeutics and Clinical Risk Management 2011, 7:387-392
Published Date: 9 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy
McIlduff CE, Rutkove SB
Therapeutics and Clinical Risk Management 2011, 7:377-385
Published Date: 5 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
Tolman JA, Faulkner MA
Therapeutics and Clinical Risk Management 2011, 7:367-375
Published Date: 1 September 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effect of a physician-targeted intervention on metoclopramide prescribing practice
Yang YX, Leonard CE, Freeman C, Hennessy S
Therapeutics and Clinical Risk Management 2011, 7:359-365
Published Date: 22 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of ciclesonide for the maintenance treatment of asthma
Singas E, Karpel JP
Therapeutics and Clinical Risk Management 2011, 7:351-358
Published Date: 19 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Serum sodium disorders in patients with traumatic brain injury
Paiva WS, Bezerra DA, Amorim RL, Figueiredo EG, Tavares WM, De Andrade AF, Teixeira MJ
Therapeutics and Clinical Risk Management 2011, 7:345-349
Published Date: 11 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
Ali AK
Therapeutics and Clinical Risk Management 2011, 7:337-344
Published Date: 9 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of age on semen parameters in infertile men after varicocelectomy
Hassanzadeh-Nokashty K, Yavarikia P, Ghaffari A, Hazhir S, Hassanzadeh M
Therapeutics and Clinical Risk Management 2011, 7:333-336
Published Date: 9 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
Häberle J
Therapeutics and Clinical Risk Management 2011, 7:327-332
Published Date: 2 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution
Mösges R, Nematian-Samani M, Eichel A
Therapeutics and Clinical Risk Management 2011, 7:325-326
Published Date: 27 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current and emerging treatments for the management of myasthenia gravis
Sathasivam S
Therapeutics and Clinical Risk Management 2011, 7:313-323
Published Date: 22 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N
Therapeutics and Clinical Risk Management 2011, 7:301-311
Published Date: 26 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dexmedetomidine hydrochloride as a long-term sedative
Kunisawa T
Therapeutics and Clinical Risk Management 2011, 7:291-299
Published Date: 11 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy
Kymes SM, Burk C, Feinman T, Williams JM, Hollander DA
Therapeutics and Clinical Risk Management 2011, 7:283-290
Published Date: 12 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H
Therapeutics and Clinical Risk Management 2011, 7:275-281
Published Date: 5 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Conestat alfa for the treatment of angioedema attacks
Davis B, Bernstein JA
Therapeutics and Clinical Risk Management 2011, 7:265-273
Published Date: 1 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H
Therapeutics and Clinical Risk Management 2011, 7:257-264
Published Date: 29 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Propofol-based deep sedation for endoscopic retrograde cholangiopancreatography procedure in sick elderly patients in a developing country
Amornyotin S, Kachintorn U, Chalayonnawin W, Kongphlay S
Therapeutics and Clinical Risk Management 2011, 7:251-255
Published Date: 27 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical potential of lurasidone in the management of schizophrenia
Samalin L, Garnier M, Llorca PM
Therapeutics and Clinical Risk Management 2011, 7:239-250
Published Date: 27 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
Masumori N
Therapeutics and Clinical Risk Management 2011, 7:227-238
Published Date: 23 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New form of administering chlorhexidine for treatment of denture-induced stomatitis
Ryalat S, Darwish R, Amin W
Therapeutics and Clinical Risk Management 2011, 7:219-225
Published Date: 14 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
Abdel-Razeq H, Ismael Y
Therapeutics and Clinical Risk Management 2011, 7:213-217
Published Date: 14 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Diclofenac gel in the treatment of actinic keratoses
Nelson CG
Therapeutics and Clinical Risk Management 2011, 7:207-211
Published Date: 15 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
Devesa J, Alonso B, Casteleiro N, Couto P, Castañón B, Zas E, Reimunde P
Therapeutics and Clinical Risk Management 2011, 7:199-206
Published Date: 30 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
If you don't take it – it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy
Adachi JD, Josse RG, Russell RG
Therapeutics and Clinical Risk Management 2011, 7:181-198
Published Date: 24 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Accidental ingestion of BiTine ring and a note on inefficient ring separation forceps
Baghele ON, Baghele MO
Therapeutics and Clinical Risk Management 2011, 7:173-179
Published Date: 24 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
Mortazavi F, Soleimani Khiavi Y
Therapeutics and Clinical Risk Management 2011, 7:167-171
Published Date: 27 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis
Fraser LA, Vogt KN, Adachi JD, Thabane L
Therapeutics and Clinical Risk Management 2011, 7:157-166
Published Date: 9 May 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants
Maclean JR, Pfister M, Zhou Z, Roy A, Tuomari VA, Heifets M
Therapeutics and Clinical Risk Management 2011, 7:149-156
Published Date: 11 April 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gynecomastia – evaluation and current treatment options
Murad MH, Johnson RE, Kermott CA
Therapeutics and Clinical Risk Management 2011, 7:145-148
Published Date: 28 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Atrial fibrillation and the use of oral bisphosphonates
Michael Pazianas, Cyrus Cooper, Yiting Wang, et al
Therapeutics and Clinical Risk Management 2011, 7:131-144
Published Date: 22 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of Huntington’s disease: role of tetrabenazine
Marina de Tommaso, Claudia Serpino, Vittorio Sciruicchio
Therapeutics and Clinical Risk Management 2011, 7:123-129
Published Date: 21 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Broadening the use of antiretroviral therapy: the case for feline leukemia virus
Willie M Greggs III, Christine L Clouser, Steven E Patterson, et al
Therapeutics and Clinical Risk Management 2011, 7:115-122
Published Date: 16 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil Bhandari
Therapeutics and Clinical Risk Management 2011, 7:103-113
Published Date: 15 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Inferior vena cava filters in cancer patients: to filter or not to filter
Hikmat Abdel-Razeq, Asem Mansour, Yousef Ismael, et al
Therapeutics and Clinical Risk Management 2011, 7:99-102
Published Date: 10 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A causative link between periodontal disease and glomerulonephritis: a preliminary study
Mohammad Reza Ardalan, Kamyar Ghabili, Reza Pourabbas, et al
Therapeutics and Clinical Risk Management 2011, 7:93-98
Published Date: 8 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacological and clinical overview of cloperastine in treatment of cough
Maria Antonietta Catania, Salvatore Cuzzocrea
Therapeutics and Clinical Risk Management 2011, 7:83-92
Published Date: 7 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Enzyme replacement therapy for Fabry disease: some answers but more questions
Majid Alfadhel, Sandra Sirrs
Therapeutics and Clinical Risk Management 2011, 7:69-82
Published Date: 25 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk
Daniele Franchi, Davide Cini, Giorgio Iervasi
Therapeutics and Clinical Risk Management 2011, 7:59-68
Published Date: 17 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation
Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al
Therapeutics and Clinical Risk Management 2011, 7:53-58
Published Date: 17 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Genitourinary system trauma after 2003 Bam earthquake in Kerman, Iran
Mohammad Hasan Dehghani Firoozabadi, Mehdi Abedinzadeh, Mohammad Kazem Moslemi
Therapeutics and Clinical Risk Management 2011, 7:49-52
Published Date: 9 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pirfenidone treatment of idiopathic pulmonary fibrosis
Ye Gan, Erica L Herzog, Richard H Gomer
Therapeutics and Clinical Risk Management 2011, 7:39-47
Published Date: 8 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Paroxysmal atrial fibrillation in cryptogenic stroke
Neha S Dangayach, Kevin Kane, Majaz Moonis
Therapeutics and Clinical Risk Management 2011, 7:33-37
Published Date: 28 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The lupus band test in systemic lupus erythematosus patients
Adam Reich, Katarzyna Marcinow, Rafal Bialynicki-Birula
Therapeutics and Clinical Risk Management 2011, 7:27-32
Published Date: 24 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Investigation of pulmonary infection pathogens in neurological intensive care unit
Fengying Quan, Guangwei Liu, Liang Wang, et al
Therapeutics and Clinical Risk Management 2011, 7:21-25
Published Date: 21 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
Maria Adriana Cataldo, Nicola Petrosillo
Therapeutics and Clinical Risk Management 2011, 7:13-20
Published Date: 13 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of rituximab in first-line treatment of chronic lymphocytic leukemia
Jeffrey Bryan, Gautam Borthakur
Therapeutics and Clinical Risk Management 2011, 7:1-11
Published Date: 22 December 2010